Podestà, M. A., Ruggiero, B., Remuzzi, G., & Ruggenenti, P. (2020). Ofatumumab for multirelapsing membranous nephropathy complicated by rituximab-induced serum-sickness. BMJ Case Rep.
Dyfyniad Arddull ChicagoPodestà, Manuel Alfredo, Barbara Ruggiero, Giuseppe Remuzzi, and Piero Ruggenenti. "Ofatumumab for Multirelapsing Membranous Nephropathy Complicated By Rituximab-induced Serum-sickness." BMJ Case Rep 2020.
Dyfyniad MLAPodestà, Manuel Alfredo, Barbara Ruggiero, Giuseppe Remuzzi, and Piero Ruggenenti. "Ofatumumab for Multirelapsing Membranous Nephropathy Complicated By Rituximab-induced Serum-sickness." BMJ Case Rep 2020.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.